Skip to main content

Table 1 Characteristics of the 427 patients with HIV/HBV co-infection according to anti-HBV treatment status

From: Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy

Characteristics Never treated patients (n = 53) Treated patients (n = 374) All patients (n = 427) P
N. enrolled per center, %     
≥20 patients 60.4 52.9 53.9 0.31
Female gender, % 22.6 24.3 24.1 0.79
Immigrant status, %     
foreign birth 18.9 16.8 17.1 0.71
Median age at diagnosis§, years     
(IQR) 35 (31–43) 35 (29–42) 35 (30–42) 0.81
Years since HBV diagnosis°, %     <0.001
<2 32.1 7 10.1
2-10 52.8 59.9 59
>10 15.1 32.4 30.2
Alcohol consumption*, %     0.22
never 15.1 18.7 18.3
ever 60.4 47.6 49.2
not available 24.5 33.7 32.6
Disease stage, %     
cirrhosis/HCC 3.8 9.4 8.7 0.18
HBeAg, %     0.17
positivity 28.3 35.8 34.9
not available 1.9 0.3 0.5
HCV co-infection, %     0.4
yes 24.5 33.4 32.3
not available -- 0.3 0.2
HDV co-infection, %     0.07
yes 7.5 19.8 18.3
not available 9.4 5.9 6.3
  1. §computed on 424 patients; °3 patients not available; * ≥ 20 g/day during at least 6 consecutive months life-time; IQR, interquartile range; HCC, hepatocellular carcinoma.